dihydroxyphenylalanine has been researched along with Nausea in 80 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Bromocriptin dosage was gradually increased to a total dose of 30 - 40 mg daily." | 2.65 | [Bromocriptin in the treatment of progressive stages of Parkinson's disease (author's transl)]. ( Fischer, PA; Schneider, E, 1982) |
| " All patients entering the trial were taking anticholinergic drugs in stable dosage and these were continued throughout." | 2.64 | L-dopa in Parkinsonism and the influence of previous thalamotomy. ( Hughes, RC; Polgar, JG; Walton, JN; Weightman, D, 1971) |
| "The clinical actions of levodopa in Parkinsonism, given with and without an extracerebral decarboxylase in hibitor, L-alpha-methyldopahydrazine, were compared." | 2.64 | Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa. ( Calne, DB; Gawler, J; Hilson, A; Pallis, CA; Petrie, A; Rao, S; Reid, JL; Thomas, PK; Vakil, SD, 1971) |
| " Improvement was sustained during this period even though the average daily dosage of L-dopa was reduced." | 2.63 | Treatment of Parkinsonism with Laevo-dopa. ( Mawdsley, C, 1970) |
| " On the basis of this experience it seems that the drug can be used safely and effectively on an outpatient basis provided that dosage increments are introduced gradually, maximum dosage is limited to 4 g." | 1.25 | Metabolic studies and clinical observations during L-dopa treatment of Parkinson's disease. ( Bianchine, JR; Peaston, MJ, 1970) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 79 (98.75) | 18.7374 |
| 1990's | 1 (1.25) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schneider, E | 1 |
| Fischer, PA | 1 |
| Murakawa, M | 1 |
| Adachi, T | 1 |
| Nakao, S | 1 |
| Seo, N | 1 |
| Shingu, K | 1 |
| Mori, K | 1 |
| Hunter, KR | 3 |
| Stern, GM | 4 |
| Laurence, DR | 3 |
| Rinne, UK | 3 |
| Sonninen, V | 2 |
| Sirtola, T | 1 |
| Fehling, C | 1 |
| Coppen, A | 1 |
| Metcalfe, M | 1 |
| Carroll, JD | 1 |
| Morris, JG | 1 |
| Shaw, KM | 1 |
| Carter, AB | 2 |
| Marsden, CD | 1 |
| Parkes, JD | 3 |
| Rees, JE | 1 |
| Sandler, M | 1 |
| Ruthven, CR | 1 |
| Goodwin, BL | 1 |
| Antonini, F | 1 |
| Baroni, A | 1 |
| Bucalossi, A | 1 |
| Roveyaz, L | 1 |
| Cotzias, GC | 1 |
| Papavasiliou, PS | 1 |
| Gellene, R | 1 |
| Calne, DB | 2 |
| Spiers, AS | 1 |
| Godwin-Austen, RB | 2 |
| Frears, CC | 2 |
| Bergmann, S | 2 |
| Knill-Jones, RP | 2 |
| Porter, BA | 1 |
| Rosenfield, RL | 1 |
| Lawrence, AM | 1 |
| Birkmayer, W | 2 |
| Van Woert, MH | 1 |
| Ambani, LM | 1 |
| Levine, RJ | 1 |
| Passeri, M | 1 |
| Ceccato, S | 1 |
| Mones, RJ | 1 |
| Dupont, E | 3 |
| Hansen, E | 2 |
| Melsens, S | 1 |
| Parkenberg, H | 1 |
| Holm, P | 1 |
| Boudin, G | 1 |
| Pépin, B | 1 |
| Guillard, A | 1 |
| Fabiani, JM | 1 |
| Haguenau, M | 1 |
| Völler, GW | 1 |
| Muschard, F | 1 |
| Wälzholz, U | 2 |
| Moorthy, S | 1 |
| Grendahl, H | 1 |
| Andersen, A | 1 |
| Müller, C | 1 |
| Náhunek, K | 1 |
| Svestka, J | 1 |
| Kamenická, V | 1 |
| Rodová, A | 1 |
| Boshes, B | 1 |
| Presthus, J | 2 |
| Schwartz, AM | 2 |
| Olanow, CW | 1 |
| Spencer, A | 1 |
| Andrews, CJ | 1 |
| Somerville, B | 1 |
| Schönfelder, H | 1 |
| Holmsen, R | 1 |
| Haleem, MA | 1 |
| Selby, G | 1 |
| Battista, AF | 1 |
| Wolff, BB | 1 |
| Laitinen, LV | 1 |
| Hildick-Smith, M | 1 |
| Markham, C | 1 |
| Diamond, SG | 1 |
| Treciokas, LJ | 1 |
| Knutsson, E | 2 |
| Mårtensson, A | 2 |
| Mawdsley, C | 1 |
| Matussek, N | 1 |
| Benkert, O | 1 |
| Schneider, K | 1 |
| Otten, H | 1 |
| Pohlmeier, H | 1 |
| Hughes, RC | 1 |
| Polgar, JG | 1 |
| Weightman, D | 1 |
| Walton, JN | 1 |
| Lipman, IJ | 1 |
| Zilkha, KJ | 1 |
| Clements, PJ | 1 |
| Baxter, R | 1 |
| Siirtola, T | 1 |
| Reid, JL | 1 |
| Vakil, SD | 1 |
| Rao, S | 1 |
| Petrie, A | 1 |
| Pallis, CA | 1 |
| Gawler, J | 1 |
| Thomas, PK | 1 |
| Hilson, A | 1 |
| Pakkenberg, H | 1 |
| Garde, B | 1 |
| Melsen, S | 1 |
| Vestberg, F | 1 |
| Worm-Petersen, J | 1 |
| Mikkelsen, B | 1 |
| Weiss, JL | 1 |
| Chase, TN | 1 |
| Critchley, E | 1 |
| Mars, H | 2 |
| Libman, I | 1 |
| Gillo-Joffroy, L | 2 |
| Barbeau, A | 2 |
| Görlich, J | 1 |
| Markus, E | 1 |
| Duvoisin, RC | 2 |
| Reveno, WS | 1 |
| Bauer, RB | 1 |
| Rosenbaum, H | 1 |
| Guidetti, B | 1 |
| Giuffrè, R | 1 |
| O'Doherty, DS | 1 |
| Greenburg, J | 1 |
| Gutmann, L | 1 |
| Martin, JD | 1 |
| Gutrecht, JA | 1 |
| Martin, WE | 1 |
| Stern, G | 1 |
| Klawans, HL | 1 |
| Garvin, JS | 1 |
| Peaston, MJ | 1 |
| Bianchine, JR | 1 |
| Siegfried, J | 1 |
| Schwieger, AC | 1 |
| Jenkins, AC | 1 |
| Landy, PJ | 1 |
| Krasner, N | 1 |
| Cornelius, JM | 1 |
| Tamarkin, NR | 1 |
| Goodwin, FK | 1 |
| Axelrod, J | 1 |
| Tissot, R | 1 |
| Gaillard, JM | 1 |
| Guggisberg, M | 1 |
| Gauthier, G | 1 |
| de Ajuriaguerra, J | 1 |
| Yahr, MD | 1 |
| Schear, MJ | 1 |
| Barrett, RE | 1 |
| Hoehn, MM | 1 |
6 reviews available for dihydroxyphenylalanine and Nausea
| Article | Year |
|---|---|
Recent advances in the treatment of Parkinsonism with drugs.
Topics: Amantadine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Arrhythmias, Cardiac; Blood-Brain | 1972 |
Therapeutic uses and side effects of L-dopa.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Barbiturates; Dihydroxyphenylalanine; Drug Synergism; | 1972 |
[Long term treatment of a parkinsonism with l-dopa].
Topics: Administration, Oral; Athetosis; Chorea; Dihydroxyphenylalanine; Humans; Nausea; Parkinson Disease; | 1973 |
Use of drugs in the treatment of parkinsonism.
Topics: Amantadine; Depression; Dihydroxyphenylalanine; Feeding and Eating Disorders; Humans; Hypertension; | 1970 |
L-dopa therapy in Parkinson's disease.
Topics: Delirium; Depression; Dihydroxyphenylalanine; Gastrointestinal Hemorrhage; Hallucinations; Humans; H | 1971 |
Levodopa in Parkinsonism.
Topics: Brain; Brain Chemistry; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Humans; Hypotension; Movem | 1971 |
25 trials available for dihydroxyphenylalanine and Nausea
| Article | Year |
|---|---|
[Bromocriptin in the treatment of progressive stages of Parkinson's disease (author's transl)].
Topics: Aged; Bromocriptine; Dihydroxyphenylalanine; Double-Blind Method; Female; Humans; Male; Middle Aged; | 1982 |
Domperidone as an anti-emetic; summary of research reports.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antiemetics; Benzimidazoles; Clinical Trials as Topic; Cranio | 1979 |
Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.
Topics: Biopsy; Carboxy-Lyases; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Combinations; Drug Sy | 1972 |
Levodopa and L-tryptophan therapy in Parkinsonism.
Topics: Aged; Depression; Dihydroxyphenylalanine; Female; Gait; Homovanillic Acid; Humans; Hydroxyindoleacet | 1972 |
A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Blood Urea Nitrogen; Dihydroxyphenylalanine; Dose-Resp | 1973 |
Modification of Parkinsonism--chronic treatment with L-dopa.
Topics: Adult; Aged; Agranulocytosis; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Urea Nitrogen; Blo | 1969 |
L-dopa in idiopathic parkinsonism.
Topics: Clinical Trials as Topic; Dihydroxyphenylalanine; Humans; Hypotension, Orthostatic; Mental Disorders | 1969 |
Combined treatment of parkinsonism with L-dopa and amantadine.
Topics: Aged; Amantadine; Chorea; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Humans; Hypotens | 1970 |
[10 years of L-DOPA therapy of Parkinson's syndrome].
Topics: Administration, Oral; Amphetamine; Animals; Brain Chemistry; Catecholamines; Clinical Trials as Topi | 1971 |
Clinical effects of para-chlorophenylalanine in Parkinson's disease.
Topics: Aged; Benztropine; Brain; Clinical Trials as Topic; Depression; Dihydroxyphenylalanine; Evaluation S | 1972 |
[Management of Parkinson's syndrome using levadopa. Results of a long-term study].
Topics: Administration, Oral; Adult; Aged; Antiparkinson Agents; Clinical Trials as Topic; Depression; Dihyd | 1972 |
The haemodynamic effect of intravenous injection of levodopa.
Topics: Adult; Aged; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiac Volume; Clinical Trial | 1972 |
Preliminary clinical experience with L-dopa in endogenous depressions.
Topics: Clinical Trials as Topic; Depression; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; H | 1972 |
A double-blind controlled study of MK-486 in Parkinson's disease.
Topics: Aged; Anorexia Nervosa; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Dihydroxyphenylal | 1973 |
Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
Topics: Adult; Aged; Carbidopa; Carboxy-Lyases; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Thera | 1974 |
Treatment of Parkinsonism with Laevo-dopa.
Topics: Adult; Aged; Clinical Trials as Topic; Dihydroxyphenylalanine; Feeding and Eating Disorders; Female; | 1970 |
[Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions].
Topics: Adolescent; Adult; Aged; Blood Pressure; Carboxy-Lyases; Clinical Trials as Topic; Depression; Dihyd | 1970 |
L-dopa in Parkinsonism and the influence of previous thalamotomy.
Topics: Aged; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Humans; Hypertension; Hypotension; M | 1971 |
L-dopa and amantadine hydrochloride in Parkinson's disease.
Topics: Adult; Aged; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Disability Evaluation; Fe | 1971 |
L-Dopa treatment in Parkinson's Disease.
Topics: Age Factors; Anorexia Nervosa; Cardiovascular Diseases; Clinical Trials as Topic; Dihydroxyphenylala | 1970 |
Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.
Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Clinical Trials as Topic; Dihydroxyphenyl | 1971 |
Effect of age and arteriosclerosis on the response of Parkinsonian patients to levodopa.
Topics: Age Factors; Aged; Antiemetics; Arteriosclerosis; Clinical Trials as Topic; Dihydroxyphenylalanine; | 1971 |
[Levodopa and Parkinsonism. A double-blind study].
Topics: Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Dihydroxyphenylalanine; | 1971 |
[L-Dopa therapy in Parkinson's disease. A double-blind study].
Topics: Adult; Aged; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Na | 1971 |
[L-dopa therapy of Parkinson's syndrome. Comparison of pure L-dopa and the combination preparation L-dopa and decarboxylase inhibitor].
Topics: Carboxy-Lyases; Dihydroxyphenylalanine; Drug Combinations; Female; Humans; Hyperkinesis; Male; Middl | 1972 |
49 other studies available for dihydroxyphenylalanine and Nausea
| Article | Year |
|---|---|
Activation of the cortical and medullary dopaminergic systems by nitrous oxide in rats: a possible neurochemical basis for psychotropic effects and postanesthetic nausea and vomiting.
Topics: Anesthesia; Animals; Biogenic Amines; Brain; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Hy | 1994 |
Use of levodopa with other drugs.
Topics: Adult; Aged; Antidepressive Agents; Antiemetics; Digoxin; Dihydroxyphenylalanine; Diuretics; Drug An | 1970 |
L-dopa. II.
Topics: Anorexia Nervosa; Cardiac Complexes, Premature; Dihydroxyphenylalanine; Drug Synergism; Humans; Hypo | 1970 |
Treatment of Parkinson's syndrome with L-DOPA on an out-patient basis.
Topics: Age Factors; Aged; Ambulatory Care; Dihydroxyphenylalanine; Female; Humans; Hypotension, Orthostatic | 1972 |
Sustained levodopa therapy in parkinsonism.
Topics: Activities of Daily Living; Aged; Cognition Disorders; Dihydroxyphenylalanine; Drug Evaluation; Faci | 1973 |
Letter: Pyridoxine contraindicated in parkinsonism.
Topics: Dihydroxyphenylalanine; Drug Antagonism; Humans; Metoclopramide; Nausea; Parkinson Disease; Pyridoxi | 1973 |
Variation of levodopa metabolism with gastrointestinal absorption site.
Topics: Administration, Oral; Aged; Animals; Biotransformation; Catechols; Dihydroxyphenylalanine; Dogs; Duo | 1974 |
[Study of L-dopa treatment and its principal side effects in aged subjects].
Topics: Aged; Antidepressive Agents; Asthenia; Cardiovascular Diseases; Circadian Rhythm; Dihydroxyphenylala | 1972 |
The levodopa test of growth hormone reserve in children.
Topics: Adolescent; Adult; Arginine; Blood Glucose; Child; Child, Preschool; Dihydroxyphenylalanine; Follicl | 1973 |
[Significance of transmethylation and S-adenosylmethionine (SAM) in the management of Parkinson's disease with L-dopa].
Topics: Adenosine; Aged; Brain; Digestive System; Dihydroxyphenylalanine; Feeding and Eating Disorders; Fema | 1972 |
Parkinson's disease treated with L-dopa. Three-year follow-up report.
Topics: Dihydroxyphenylalanine; Follow-Up Studies; Humans; Mental Disorders; Movement Disorders; Nausea; Par | 1972 |
Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone).
Topics: Administration, Oral; Aromatic Amino Acid Decarboxylase Inhibitors; Capsules; Dihydroxyphenylalanine | 1972 |
[Indications and results of monoamine treatment in parkinsonian syndromes].
Topics: Aged; Arrhythmias, Cardiac; Benserazide; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Combinations; | 1972 |
Efficacy of and possible differences in tolerance to L-dopa tablets with different rates of release of the active substance.
Topics: Administration, Oral; Arrhythmias, Cardiac; Dihydroxyphenylalanine; Drug Tolerance; Feeding and Eati | 1974 |
[Advances in L-DOPA therapy for parkinsonism through combination with a decarboxylase inhibitor. Results of a long-term study].
Topics: Adult; Aged; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Hydrazines; Long-Term Care; Mal | 1972 |
[Long-term treatment of Parkinsonism with L-dopa].
Topics: Adult; Aged; Anorexia Nervosa; Dihydroxyphenylalanine; Female; Humans; Long-Term Care; Male; Mental | 1972 |
L-dopa in the treatment of parkinsonism.
Topics: Aged; Arrhythmias, Cardiac; Arteriosclerosis; Aspartate Aminotransferases; Blood Urea Nitrogen; Dihy | 1972 |
Levodopa and related drugs.
Topics: Amantadine; Apomorphine; Dihydroxyphenylalanine; Humans; Hydrazines; Hypotension; Mental Disorders; | 1973 |
Levodopa in parkinson's disease--Australian collaborative trial.
Topics: Activities of Daily Living; Adult; Age Factors; Aged; Australia; Bone Marrow; Dihydroxyphenylalanine | 1973 |
Levodopa and induced-pain response. A study of patients with Parkinsonian and pain syndromes.
Topics: Aged; Cold Temperature; Dihydroxyphenylalanine; Electric Stimulation; Female; Hot Temperature; Human | 1973 |
Slowly absorbed L-dopa preparation in the treatment of parkinsonism.
Topics: Administration, Oral; Adult; Aged; Carbon Radioisotopes; Delayed-Action Preparations; Dihydroxypheny | 1973 |
The patient's view of L-Dopa after one year's therapy.
Topics: Aged; Blood Pressure; Cognition Disorders; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; | 1973 |
Letter: Pyridoxine and Parkinsonism.
Topics: Dihydroxyphenylalanine; Humans; Nausea; Parkinson Disease; Pyridoxine | 1973 |
Carbidopa in Parkinson disease and in nausea and vomiting of levodopa.
Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Hum | 1974 |
Improvement in mono-manual dexterity in parkinsonism when supplementing levodopa with an extracerebral decarboxylase inhibitor, RO 4-4602.
Topics: Administration, Oral; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; Do | 1974 |
Levodopa and amantadine in the treatment of Parkinsonism.
Topics: Aged; Amantadine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Movement Disorders; Nau | 1972 |
L-DOPA in Parkinson's disease. Results of a co-operative study in the Montreal area.
Topics: Administration, Oral; Aged; Basal Ganglia Diseases; Constipation; Dihydroxyphenylalanine; Evaluation | 1972 |
Diphenidol for levodopa induced nausea and vomiting.
Topics: Antiemetics; Carbonates; Dihydroxyphenylalanine; Dinitrophenols; Humans; Nausea; Parkinson Disease; | 1972 |
L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
Topics: Aged; Amantadine; Chlorides; Depression; Dihydroxyphenylalanine; Drug Hypersensitivity; Female; Foll | 1971 |
A year's experience of L-DOPA in the treatment of Parkinson's disease.
Topics: Adult; Age Factors; Aged; Dihydroxyphenylalanine; Female; Functional Laterality; Humans; Hypotension | 1971 |
Levodopa in treating Parkinsonism.
Topics: Adult; Aged; Athetosis; Dihydroxyphenylalanine; Female; Humans; Hypotension; Male; Middle Aged; Naus | 1971 |
[Conservative therapy in the Parkinson syndrome].
Topics: Amantadine; Antidepressive Agents; Dihydroxyphenylalanine; Humans; Imipramine; Injections, Intraveno | 1971 |
Side effects of L-dopa treatment.
Topics: Aphrodisiacs; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Movement Disorders; Nausea; | 1971 |
Quantitative effects of L-dopa on different types of movements and muscle tone in Parkinsonian patients.
Topics: Administration, Oral; Aged; Ankle Joint; Dihydroxyphenylalanine; Disability Evaluation; Female; Gait | 1971 |
L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University).
Topics: Dihydroxyphenylalanine; Female; Humans; Male; Movement Disorders; Nausea; Parkinson Disease; Vomitin | 1970 |
Adverse clinical side effects of levodopa therapy.
Topics: Antiparkinson Agents; Arrhythmias, Cardiac; Benserazide; Carboxy-Lyases; Dihydroxyphenylalanine; Ede | 1971 |
Adverse reactions during treatment of Parkinson's disease with levodopa.
Topics: Adult; Aged; Coombs Test; Depression; Dihydroxyphenylalanine; Duodenal Ulcer; Female; Gastrointestin | 1971 |
Parkinsonism.
Topics: Agranulocytosis; Dihydroxyphenylalanine; Humans; Middle Aged; Nausea; Orphenadrine; Parasympatholyti | 1969 |
Treatment of parkinsonism with L-dopa (study of 105 patients).
Topics: Adolescent; Adult; Age Factors; Aged; Alkaline Phosphatase; Anorexia Nervosa; Aspartate Aminotransfe | 1969 |
A second report on Levodopa.
Topics: Amantadine; Arrhythmias, Cardiac; Cerebrovascular Disorders; Dihydroxyphenylalanine; Humans; Hypoten | 1969 |
Metabolic studies and clinical observations during L-dopa treatment of Parkinson's disease.
Topics: Age Factors; Aged; Athetosis; Carbon Isotopes; Chorea; Dihydroxyphenylalanine; Female; Humans; Intes | 1970 |
[Two years experience with L-DOPA in association with a decarboxylase inhibitor].
Topics: Acute Disease; Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; Humans; Hypoten | 1970 |
Specific therapy in Parkinson's disease.
Topics: Amantadine; Dihydroxyphenylalanine; Humans; Hypotension, Orthostatic; Nausea; Parkinson Disease; Vom | 1970 |
Observations on the effect of amantadine hydrochloride in the treatment of Parkinsonism.
Topics: Aged; Amantadine; Depression; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Muscle Tonu | 1970 |
L-Dopa in the treatment of Parkinson's disease.
Topics: Activities of Daily Living; Aged; Dihydroxyphenylalanine; Hallucinations; Humans; Hypotension; Middl | 1970 |
L-dopa for postencephalitic Parkinsonism.
Topics: Aged; Depression; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Nausea; Parkinson Disea | 1970 |
Rapid elevation of biogenic amine metabolites in human CSF following probenecid.
Topics: Administration, Oral; Affective Symptoms; Dihydroxyphenylalanine; Female; Headache; Humans; Hydroxyi | 1970 |
[Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].
Topics: Adult; Aged; Anemia, Hemolytic; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Cell Count; Carb | 1969 |
Treatment of parkinsonism with levodopa.
Topics: Adult; Aged; Anorexia Nervosa; Arrhythmias, Cardiac; Dihydroxyphenylalanine; Female; Gait; Humans; H | 1969 |